VJHemOnc is committed to improving our service to you

EBMT 2020 | Pharmacotherapy and individualization in pediatric HSCT

VJHemOnc is committed to improving our service to you

Jaap Jan Boelens

Jaap Jan Boelens, MD, PhD, Memorial Sloan Kettering Cancer Center, New York, NY, discusses pharmacotherapy in pediatric hematopoietic stem cell transplantation (HSCT) and how individualized dosing in HSCT may improve outcomes. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter